Source: Pharma Manufacturing
More...
FDA Panel Backs Valeant Psoriasis Drug, Despite Suicide Risk
FDA advisors voted to approve Valeant's experimental psoriasis drug, brodalumab, provided the drugmaker takes extra steps to mitigate possible suicide risk associated with the drug.
